Zhejiang Tailin Bioengineering Co Ltd (300813) — Net Asset Quality Index

Latest as of March 2026: 85.2%

Zhejiang Tailin Bioengineering Co Ltd (300813) has a Net Asset Quality Index of 85.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥946.91 Million minus total liabilities of CN¥140.46 Million yields net assets of CN¥806.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Zhejiang Tailin Bioengineering Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Quality Index

85.2%
Equity / Total Assets

Net Assets

CN¥806.45 Million
CNY

Total Assets

CN¥946.91 Million
CNY

Total Liabilities

CN¥140.46 Million
CNY

Zhejiang Tailin Bioengineering Co Ltd Net Asset Quality Index Over Time (2013–2025)

This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 85.2%, representing net assets of CN¥806.45 Million against total assets of CN¥946.91 Million CNY. See 300813 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

The table below presents the year-by-year Net Asset Quality Index for Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Zhejiang Tailin Bioengineering Co Ltd stock valuation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 83.8% CN¥804.29 Million CN¥959.34 Million CN¥155.04 Million ▼ -1.7 pp
2024 85.5% CN¥820.73 Million CN¥959.91 Million CN¥139.18 Million ▲ +18.7 pp
2023 66.8% CN¥650.24 Million CN¥973.51 Million CN¥323.27 Million ▼ -3.4 pp
2022 70.2% CN¥647.45 Million CN¥922.66 Million CN¥275.21 Million ▼ -5.7 pp
2021 75.8% CN¥497.38 Million CN¥655.87 Million CN¥158.49 Million ▼ -6.4 pp
2020 82.3% CN¥444.24 Million CN¥539.99 Million CN¥95.75 Million ▼ -3.6 pp
2019 85.8% CN¥229.11 Million CN¥266.91 Million CN¥37.81 Million ▲ +9.5 pp
2018 76.3% CN¥194.70 Million CN¥255.12 Million CN¥60.42 Million ▲ +0.6 pp
2017 75.7% CN¥146.48 Million CN¥193.59 Million CN¥47.10 Million ▲ +1.1 pp
2016 74.6% CN¥116.31 Million CN¥155.97 Million CN¥39.66 Million ▲ +0.3 pp
2015 74.2% CN¥97.42 Million CN¥131.22 Million CN¥33.79 Million ▲ +4.0 pp
2014 70.2% CN¥55.04 Million CN¥78.39 Million CN¥23.35 Million ▼ -9.0 pp
2013 79.2% CN¥64.92 Million CN¥81.97 Million CN¥17.06 Million
pp = percentage points